Les Ulis, France

Ratremaniaina Z Andriamialisoa


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1981-1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ratremaniaina Z Andriamialisoa: Innovator in Chemical Compounds

Introduction

Ratremaniaina Z Andriamialisoa is a notable inventor based in Les Ulis, France. He has made significant contributions to the field of chemistry, particularly in the development of new chemical compounds that have potential applications as drugs. With a total of 2 patents to his name, Andriamialisoa is recognized for his innovative approach to medicinal chemistry.

Latest Patents

His latest patents include a class of seco bis-indolic compounds that can be utilized as drugs. These compounds are characterized by a specific formula that allows for various substitutions, making them versatile in their application. Additionally, he has developed bis-indole compounds that exhibit antitumoral activity, showcasing their potential as medicaments. The detailed chemical structures and functionalities of these compounds highlight their significance in pharmaceutical research.

Career Highlights

Andriamialisoa is associated with the Agence Nationale De Valorisation De La Recherche (ANVAR), where he continues to explore and innovate in the realm of chemical compounds. His work is pivotal in advancing the understanding of how these compounds can be used in medical applications, particularly in the fight against cancer.

Collaborations

Throughout his career, Andriamialisoa has collaborated with notable colleagues, including Nicole Langlois and Yves Langlois. These partnerships have contributed to the successful development of his patented compounds and have fostered a collaborative environment for research and innovation.

Conclusion

Ratremaniaina Z Andriamialisoa stands out as a significant figure in the field of chemical innovation. His contributions to the development of new drug compounds reflect his dedication to advancing medical science. His work continues to inspire future research in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…